Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...

Left atrial appendage closure is an alternative strategy for stroke prophylaxis, Wazni and colleagues noted. "The safety and ...

The sFlt-1/PlGF ratio did not effectively gauge future preeclampsia risk in pregnant patients with SLE and proteinuria.

CHICAGO -- Researchers failed to prevent cognitive impairment in people with existing atrial fibrillation (Afib) by going the ...

AstraZeneca Plc’s recent share-price rout has gone so far that the pharma stock has shaken off the last of its bearish ...

Charity Breast Cancer Now has described the failure to negotiate a fair price of Enhertu as “utterly heartbreaking”.

Berenberg lowered the firm’s price target on AstraZeneca (AZN) to EUR 140 from EUR 150 and keeps a Buy rating on the shares. Within the space ...

UBS upgraded AstraZeneca (AZN) to Neutral from Sell with an unchanged price target of 11,300 GBp. The firm cites the stock’s 24% decline over ...

AstraZeneca said it is doubling down on its investment in its U.S. business. Meanwhile, General Catalyst has agreed to ...

BRITISH pharmaceutical giant AstraZeneca is investing US$3.5bn into expanding its research and development (R&D) operations ...

Shares of AstraZeneca (LON: AZN) traded higher on Wednesday after UBS revised its recommendation for the pharmaceutical giant ...

AstraZeneca PLC aims for $80 billion revenue by 2030 through strong growth in oncology, biopharmaceuticals, and rare diseases ...